The very first COVID-19 Vaccine that's been actively tested in the U.S., is now ready for a final test, according to AP News.   Dr. Anthony Fauci, the U.S. government’s top infectious disease Doctor, said this:

“No matter how you slice this, this is good news"

The Associated Press news article claims that an experimental vaccine, that was developed at the National Institutes of Health and Moderna Inc., will begin its final testing around July 27.  The vaccine will be administered to 30,000-people to prove if the shots really work to protect against the coronavirus.

Enter your number to get our free mobile app

If you are interested in volunteering to be involved in 'future COVID-19 prevention clinical trials', the Associated Press has provided a link to the CoVPN Volunteer Screening Registry.  According to the Registry website:

The purpose of this screening registry is to create a list of potential volunteers who want to take part in current or future COVID-19 prevention clinical trials. You must be 18 years or older to participate. Participation involves completing a short online survey that includes some personal questions. Your participation is voluntary. This survey typically takes about 10 minutes to complete.

The Associated Press article says this about the final clinical vaccine trial testing:

The 30,000-person study will mark the world’s largest study of a potential COVID-19 vaccine so far. And the NIH-developed shot isn’t the only one set for such massive U.S. testing, crucial to spot rare side effects. The government plans similar large studies of the Oxford candidate and another by Johnson & Johnson; separately, Pfizer Inc. is planning its own huge study.

Dr. Fauci, Director of NIH's National Institute of Allergy and Infectious Diseases, according to the Associated Press, said that people think,

“this is a race for one winner. Me, I’m cheering every one of them on.We need multiple vaccines. We need vaccines for the world, not only for our own country.”